Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275).

MLA

Francolini, G., et al. “Prospective Assessment of AR Splice Variant and PSMA Detection on Circulating Tumor Cells of MCRPC Patients: Preliminary Analysis of Patients Enrolled in PRIMERA Trial (NCT04188275).” Clinical & Experimental Metastasis, vol. 38, no. 5, Oct. 2021, pp. 451–58. EBSCOhost, https://doi.org/10.1007/s10585-021-10118-7.

APA

Francolini, G., Loi, M., Salvestrini, V., Mangoni, M., Detti, B., Di Cataldo, V., Aquilano, M., Pinzani, P., Salvianti, F., Desideri, I., Mariotti, M., Garlatti, P., Stocchi, G., Ciccone, L. P., Lucidi, S., Salvatore, G., Sottili, M., Meattini, I., & Livi, L. (2021). Prospective assessment of AR splice variant and PSMA detection on circulating tumor cells of mCRPC patients: preliminary analysis of patients enrolled in PRIMERA trial (NCT04188275). Clinical & Experimental Metastasis, 38(5), 451–458. https://doi.org/10.1007/s10585-021-10118-7

Chicago

Francolini, G, M Loi, V Salvestrini, M Mangoni, B Detti, V Di Cataldo, M Aquilano, et al. 2021. “Prospective Assessment of AR Splice Variant and PSMA Detection on Circulating Tumor Cells of MCRPC Patients: Preliminary Analysis of Patients Enrolled in PRIMERA Trial (NCT04188275).” Clinical & Experimental Metastasis 38 (5): 451–58. doi:10.1007/s10585-021-10118-7.